|
BIIB's Revenue Growth by Quarter and Year
Biogen Inc 's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
BIIB Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
2,386.30
|
2,544.00
|
2,733.80
|
2,852.60
|
III Quarter |
September |
2,530.30
|
2,508.50
|
2,778.90
|
3,376.10
|
II Quarter |
June |
2,456.00
|
2,589.10
|
2,775.00
|
3,681.60
|
I Quarter |
March |
2,463.00
|
2,531.80
|
2,694.00
|
3,534.30
|
FY |
|
9,835.60
|
10,173.40
|
10,981.70
|
13,444.60
|
BIIB Revenue fourth quarter 2023 Y/Y Growth Comment |
Biogen Inc reported decrease in Revenue in the fourth quarter 2023 by -6.2% to $ 2,386.30 millions, from the same quarter in 2022. The decrease in the fourth quarter 2023 Biogen Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 9.26%.
Looking into fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 5 other companies have achieved higher Revenue growth. While Biogen Inc ' s Revenue decline of -6.2% ranks overall at the positon no. 494 in the fourth quarter 2023.
|
BIIB Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-6.2 % |
-6.94 % |
-4.16 % |
-22.3 % |
III Quarter |
September |
0.87 % |
-9.73 % |
-17.69 % |
-6.22 % |
II Quarter |
June |
-5.14 % |
-6.7 % |
-24.63 % |
1.79 % |
I Quarter |
March |
-2.72 % |
-6.02 % |
-23.78 % |
1.28 % |
FY |
|
-3.32 % |
-7.36 % |
-18.32 % |
-6.49 % |
BIIB Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
-5.69 % |
1.42 % |
-1.62 % |
-15.51 % |
III Quarter |
September |
3.03 % |
-3.11 % |
0.14 % |
-8.3 % |
II Quarter |
June |
-0.28 % |
2.26 % |
3.01 % |
4.17 % |
I Quarter |
March |
-3.18 % |
-7.39 % |
-5.56 % |
-3.73 % |
FY (Year on Year) |
|
-3.32 % |
-7.36 % |
-18.32 % |
-6.49 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
41.42 % |
9.26 % |
-22.17 % |
(Sep. 30, 2014) |
|
(Sep 30 2021) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
41.42 % |
9.26 % |
-22.17 % |
(Sep. 30, 2014) |
|
(Sep 30 2021) |
|
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Biogen Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
80.67 % |
3.03 % |
-15.51 % |
(March 31, 2004) |
|
|
BIIB's IV. Quarter Q/Q Revenue Comment |
In the IV. Quarter 2023 Biogen Inc realized decline in Revenue from the previous quarter by -5.69% to $ 2,386.30 millions, from $ 2,530.30 millions achived in the previous quarter.
Even seasonal factors which usually fuel IV. Quarter 2023 results, have not salvage the IV. Quarter for the Biogen Inc , Laura Pérez, Biotechnology & Pharmaceuticals industry contributor pointed out, she mentioned little skepticism conserning Biogen Inc 's perspective.
Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Biogen Inc 's Revenue growth quarter on quarter, overall rank is 574. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
80.67 % |
3.03 % |
-15.51 % |
(March 31, 2004) |
|
|
BIIB's IV. Quarter Q/Q Revenue Comment |
In the IV. Quarter 2023 Biogen Inc disclosed decline in Revenue from the third quarter by -5.69% to $ 2,386.30 millions, from $ 2,530.30 millions achived a quarter before.
Even periodic factors which commonly fuel IV. Quarter 2023 Revenue, could not salvage the IV. Quarter for the Biogen Inc , Laura Pérez, Biotechnology & Pharmaceuticals industry contributor pointed out, she mentioned some pessimism conserning Biogen Inc 's perspective and mentioned that average quarter on quarter Revenue growth is at 3.03% for Biogen Inc .
Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Biogen Inc 's Revenue growth quarter on quarter, overall rank is 574. |
|
Biogen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Dec 31 2023) |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
Cumulative Revenue 12 Months Ending |
$ 9,835.60 |
$ 9,993.30 |
$ 9,971.50 |
$ 10,104.60 |
$ 10,173.40 |
Y / Y Revenue Growth (TTM) |
-3.32 % |
-3.57 % |
-6.23 % |
-6.61 % |
-7.36 % |
Year on Year Revenue Growth Overall
Ranking |
# 571 |
# 1681 |
# 141 |
# 152 |
# 2182 |
Seqeuential Revenue Change (TTM) |
-1.58 % |
0.22 % |
-1.32 % |
-0.68 % |
-1.83 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 494 |
# 1548 |
# 2644 |
# 2665 |
# 1557 |
Cumulative Revenue growth
Comment |
Biogen Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Biogen Inc 's annual Revenue decline would be -3.32% year on year to $9,836 millions.
In the Healthcare sector 60 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 571, from total ranking in previous quarter at 1681. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
41.42 % |
9.26 % |
-22.17 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
41.42 % |
9.26 % |
-22.17 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 6 |
Sector |
# 53 |
S&P 500 |
# 494 |
|
Cumulative Revenue growth
Comment |
Biogen Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Biogen Inc 's annual Revenue fall would be -3.32% year on year to $9,836 millions.
In the Healthcare sector 60 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 571, from total ranking in previous quarter at 1681. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
41.42 % |
9.26 % |
-22.17 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
41.42 % |
9.26 % |
-22.17 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 6 |
Sector |
# 53 |
S&P 500 |
# 494 |
|